Skip to content
GenoLensGenoLens

AMPD2

Chr 1p13.3

adenosine monophosphate deaminase 2

Aliases:
SPG63
MANE:
ENST00000528667.7

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Cerebellar hypoplasia

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal

+6 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • pontocerebellar hypoplasia type 9

    0.81
  • pontocerebellar hypoplasia

    0.67
  • hereditary spastic paraplegia 63

    0.65
  • Non-syndromic pontocerebellar hypoplasia

    0.49
  • Autosomal recessive spastic paraplegia type 63

    0.46
  • hereditary disease

    0.40
  • Abnormality of the nervous system

    0.34
  • spastic ataxia

    0.34
  • Global developmental delay

    0.26
  • cerebral malformation

    0.26

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

AMP deaminase 2

AMP deaminase plays a critical role in energy metabolism. Catalyzes the deamination of AMP to IMP and plays an important role in the purine nucleotide cycle

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.